Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8903 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8758 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8516 |
High Similarity |
NPD4380 |
Phase 2 |
0.8485 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8415 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8408 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8364 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8364 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8354 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8313 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8313 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8263 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8239 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8214 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8194 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8107 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8039 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7963 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7871 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7829 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7792 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7791 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7791 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7785 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7763 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7763 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7744 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7736 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7736 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7736 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7727 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7725 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7673 |
Intermediate Similarity |
NPD1511 |
Approved |
0.764 |
Intermediate Similarity |
NPD920 |
Approved |
0.764 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7607 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7588 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7578 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7564 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.753 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7485 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7485 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7471 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7456 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7443 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7443 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7432 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7421 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7354 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7341 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7302 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7294 |
Intermediate Similarity |
NPD919 |
Approved |
0.7283 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7257 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.724 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.724 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7234 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7209 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7205 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7205 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7191 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7175 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7168 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7135 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7102 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7101 |
Intermediate Similarity |
NPD37 |
Approved |
0.7093 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.709 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7081 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7076 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7037 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7033 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7029 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7024 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD1203 |
Approved |
0.701 |
Intermediate Similarity |
NPD7874 |
Approved |
0.701 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6987 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6981 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6974 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6974 |
Remote Similarity |
NPD7801 |
Approved |
0.6957 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6957 |
Remote Similarity |
NPD3748 |
Approved |
0.6957 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD3226 |
Approved |
0.6914 |
Remote Similarity |
NPD6100 |
Approved |
0.6914 |
Remote Similarity |
NPD6099 |
Approved |
0.6899 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6894 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6885 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6875 |
Remote Similarity |
NPD447 |
Suspended |
0.6871 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6869 |
Remote Similarity |
NPD7930 |
Approved |
0.6863 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD2798 |
Approved |
0.6845 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6845 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6845 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6839 |
Remote Similarity |
NPD8319 |
Approved |
0.6821 |
Remote Similarity |
NPD9545 |
Approved |
0.6821 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6807 |
Remote Similarity |
NPD6190 |
Approved |
0.68 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6795 |
Remote Similarity |
NPD2797 |
Approved |
0.6792 |
Remote Similarity |
NPD3268 |
Approved |
0.6786 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6772 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6772 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6772 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6768 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6768 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6768 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6768 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6768 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6768 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6768 |
Remote Similarity |
NPD2344 |
Approved |
0.6766 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6763 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6763 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6758 |
Remote Similarity |
NPD7240 |
Approved |
0.6757 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6753 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6752 |
Remote Similarity |
NPD1019 |
Discontinued |
0.675 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6748 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6742 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.674 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6731 |
Remote Similarity |
NPD3225 |
Approved |
0.673 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6726 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6725 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6719
|
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |